US2012016311A1PendingUtilityA1

Drug Delivery Catheters That Attach to Tissue and Methods for Their Use

41
Assignee: ALTMAN PETER APriority: Oct 13, 1999Filed: Sep 26, 2011Published: Jan 19, 2012
Est. expiryOct 13, 2019(expired)· nominal 20-yr term from priority
A61N 1/0575A61B 2018/1435A61K 9/50A61K 9/1676A61K 9/127A61B 2018/1425A61B 18/1492A61B 2018/00577A61B 2018/00011A61B 2018/00392A61B 2017/00247A61M 25/0084A61B 2018/00839A61B 2218/002A61B 2018/00351A61M 2025/0089B82Y 5/00
41
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A drug delivery catheter suited for cardiac procedures. The catheter an anchor associated with a needle, which can be used to secure the catheter to tissue for delivery of therapeutic agents to the tissue.

Claims

exact text as granted — not AI-modified
1 . A catheter system comprising of:
 transendocardial catheter having a distal end and a proximal end;   a hollow penetrating element comprising a curved needle disposed near the distal end of the transendocardial catheter;   at least one aperture in said needle for the delivery of biologic or chemical or other therapeutic agents;   a reservoir of therapeutic agent comprising a cytotherapeutic agent.   
     
     
         2 . The catheter system of  claim 1  wherein the cytotherapeutic agent is chosen from the group consisting of cytotoxic agents, chemotherapeutic agents, growth inhibitory agents, apoptotic agents, and other agents to treat cancer, such as anti-HER-2, and -anti CD20. 
     
     
         3 . The catheter system of  claim 1 , wherein the at least one aperture is disposed in a sidewall of the needle. 
     
     
         4 . The catheter system of  claim 1 , wherein the curved needle is a helical needle, and the at least one aperture is disposed in a sidewall of the helical needle. 
     
     
         5 . The catheter system of  claim 1  wherein the reservoir is disposed at the proximal end of the catheter, and the reservoir is in fluid communication with the hollow penetrating element through a lumen extending from the proximal end of the transendocardial catheter to the hollow penetrating element. 
     
     
         6 . A catheter system comprising of:
 a hollow penetrating element that is a straight needle;   at least one anchor associated with said needle and catheter, operable at the catheter handle to secure the transendocardial catheter to tissue for the stable delivery of biologic or chemical or other therapeutic agents;   at least one aperture in said needle for the delivery of biologic or chemical or other therapeutic agent;   a reservoir of therapeutic agent chosen from the group of metabolic agents, anti ischemic agents, growth factors, antiarrhythmic agents, anti-inflammatory agents, and gene therapy preparations, said reservoir in fluid communication with the at least one aperture in the needle.   
     
     
         7 . The catheter system of  claim 6 , wherein the at least one aperture is disposed in a sidewall of the needle. 
     
     
         8 . The catheter system of  claim 6 , further comprising a support structure within the delivery sheath, the support structure providing mechanical support for the hollow penetrating element. 
     
     
         9 . The catheter system of  claim 6  wherein the reservoir is disposed at the proximal end of the catheter, and the reservoir is in fluid communication with the hollow penetrating element through a lumen extending from the proximal end of the transendocardial catheter to the hollow penetrating element.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.